Pricing Log in Create free account

Moleculin Biotech, Inc. (MBRX) vs NKGen Biotech, Inc. (NKGN)

Moleculin Biotech, Inc. and NKGen Biotech, Inc. are both Biotechnology companies. Moleculin Biotech, Inc. and NKGen Biotech, Inc. are of similar size ($9.2M and $8.8M). NKGen Biotech, Inc. has negative trailing earnings, so its P/E is not meaningful; Moleculin Biotech, Inc. trades at 0.0×. Across the 9 metrics below, NKGen Biotech, Inc. leads on 5 and Moleculin Biotech, Inc. on 4.

Valuation

Metric MBRX NKGN Biotechnology median
P/E 0.04 n/m 10.26
P/S n/m n/m 9.18
P/B 0.21 n/m 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.16 n/m 0.65
EV/Sales n/m n/m 8.98
Earnings yield 2,573.95% (10,600.00%) (34.89%)
Free cash flow yield (1,027.71%) (4,296.38%) (24.52%)

Profitability

Metric MBRX NKGN Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (1,471.05%) 44.70% (50.12%)
Return on assets (152.41%) (146.49%) (45.60%)
Return on invested capital (417.27%) 0.00% 0.00%

Growth

Metric MBRX NKGN Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) 82.01% 71.38% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric MBRX NKGN Biotechnology median
Debt to equity 0.00 (0.59) 0.00
Current ratio 0.94 0.05 4.89
Net debt to EBITDA 0.35 (1.69) 1.01

Dividend

Metric MBRX NKGN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MBRX NKGN Biotechnology median
Market cap 9.16m 8.76m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack